Genewel

Genewel Co., Ltd. held a groundbreaking ceremony for a new cGMP plant in Wonju, South Korea, with an investment of 50 billion won (approx. $67 million). The facility will produce wound dressings and other medical devices, consolidating existing plants in Seongnam and Hwaseong, and is expected to create 50 new jobs.

Genewel, a life sciences company, held a groundbreaking ceremony for a new plant in Wonju, South Korea on 29 May 2025. The company will invest about KRW 50 billion to build a cGMP facility, consolidating its existing plants in Seongnam and Hwaseong, and plans to hire 50 new workers.

Genewel, a subsidiary of Dongsung Chemical, signed an MOU with Gangwon Province and Wonju City to build a new factory in Wonju Business City with an investment of 40.8 billion won by 2026, creating about 50 new jobs.